Banque Cantonale Vaudoise Decreases Position in The Allstate Co. (NYSE:ALL)

Banque Cantonale Vaudoise lessened its holdings in The Allstate Co. (NYSE:ALL) by 52.5% during the third quarter, Holdings Channel.com reports. The firm owned 5,955 shares of the insurance provider’s stock after selling 6,593 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Allstate were worth $1,129,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new stake in Allstate in the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC bought a new stake in Allstate in the 3rd quarter worth $29,000. Versant Capital Management Inc grew its holdings in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. bought a new stake in Allstate in the 2nd quarter worth $38,000. Finally, MCF Advisors LLC grew its holdings in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 0.4 %

Shares of Allstate stock opened at $197.29 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market capitalization of $52.24 billion, a PE ratio of 12.78, a price-to-earnings-growth ratio of 1.76 and a beta of 0.48. The Allstate Co. has a 52-week low of $134.17 and a 52-week high of $201.00. The company has a 50-day simple moving average of $190.76 and a two-hundred day simple moving average of $177.36.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the previous year, the company earned $0.81 earnings per share. The business’s revenue for the quarter was up 14.7% compared to the same quarter last year. On average, analysts anticipate that The Allstate Co. will post 16.01 EPS for the current fiscal year.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.87%. Allstate’s payout ratio is 23.83%.

Insider Activity

In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ALL. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Raymond James lifted their target price on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Piper Sandler lifted their target price on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research note on Friday, August 16th. Barclays lifted their target price on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday, October 31st. Finally, UBS Group lifted their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and an average price target of $214.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.